MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD9 Codes        Equipment        Hospitals        Drugs        More..
  

Useful Websites

Global Translations
Medical and Clinical Translation

specialistinfo.com
Details of over 40,000 UK Specialists and over 42,000 GPs

Global RPH
medical software

Doctors Lounge
Ask a Doctor and Disease Information

Health News
from Medical News Today.

MRCP 1 Revision
123 Doc medical courses for junior doctors.

CoreyNahman
pharmaceutical news daily

Hospital Search
Worldwide hospital database, search by country or keyword.

Metric Conversions
The Converter Site - unit conversion tool.

Drug List for Pulmonary/Respiratory Diseases

Description: Diseases having to do with the lungs and/or breathing. Studies in these areas include: Acute Respiratory Distress Syndrome (ARDS), allergy, asthma, bronchitis, cystic fibrosis, emphysema, lung disease, pneumonia, sinus infections, smoking cessation, and others.

Below the search box are the FDA approved drugs for the Pulmonary/Respiratory Diseases category. Click any link to view the full drug information.

1. Phrase:
2. Area:
3. Letter:
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

4. Show all

Results: 79
  • Accolate
  • Accolate
  • Aldurazyme (laronidase)
  • Allegra (fexofenadine hydrochloride)
  • Allegra-D
  • Alvesco (ciclesonide)
  • Astelin nasal spray
  • Atrovent (ipratropium bromide)
  • Augmentin (amoxicillin/clavulanate)
  • Avelox I.V. (moxifloxacin hydrochloride)
  • Azmacort (triamcinolone acetonide) Inhalation Aerosol
  • Biaxin XL (clarithromycin extended-release tablets)
  • Breathe Right
  • Brovana (arformoterol tartrate)
  • Cafcit Injection
  • Cedax (ceftibuten)
  • Cefazolin and Dextrose USP
  • Ceftin (cefuroxime axetil)
  • Cipro
  • Clarinex
  • Claritin RediTabs (10 mg loratadine rapidly-disintegrating tablet)
  • Claritin Syrup (loratadine)
  • Claritin-D 24 Hour Extended Release Tablets (10 mg loratadine, 240 mg pseudoephedrine sulfate)
  • Clemastine fumarate syrup
  • Covera-HS (verapamil)
  • Curosurf
  • DuoNeb (albuterol sulfate and ipratropium bromide)
  • Dynabac
  • Flonase Nasal Spray
  • Flovent Rotadisk
  • Foradil Aerolizer (formoterol fumarate inhalation powder)
  • Infasurf
  • Invanz
  • Iressa (gefitinib)
  • Ketek (telithromycin)
  • Letairis (ambrisentan)
  • Metaprotereol Sulfate Inhalation Solution, 5%
  • Nasacort AQ (triamcinolone acetonide) Nasal Spray
  • Nasacort AQ (triamcinolone acetonide) Nasal Spray
  • NasalCrom Nasal Spray
  • OcuHist
  • Omnicef
  • Patanase (olopatadine hydrochloride)
  • Priftin
  • Proventil HFA Inhalation Aerosol
  • Pulmozyme (dornase alfa)
  • Pulmozyme Inhalation Solution
  • Qvar (beclomethasone dipropionate)
  • Raxar (grepafloxacin)
  • Remodulin (treprostinil)
  • RespiGam (Respiratory Syncitial Virus Immune Globulin Intravenous)
  • Rhinocort Aqua Nasal Spray
  • Sclerosol Intrapleural Aerosol
  • Serevent
  • Singulair
  • Spiriva HandiHaler (tiotropium bromide)
  • Synagis
  • Tavist Allergy/Sinus/Headache
  • Tavist-D
  • Tequin
  • Tikosyn Capsules
  • Tilade
  • Tilade (nedocromil sodium) inhaler
  • Tilade Nebulizer Solution
  • Tobi
  • Tracleer (bosentan)
  • Tri-Nasal Spray (triamcinolone acetonide spray)
  • Tripedia (Diptheria and Tetanus Toxoids and Acellular Pertussis Vaccine Absorbed)
  • Vancenase AQ 84 mcg Double Strength
  • Vanceril 84 mcg Double Strength (beclomethasone dipropionate, 84 mcg) Inhalation Aerosol
  • Ventolin HFA (albuterol sulfate inhalation aerosol)
  • Visipaque (iodixanol)
  • Xopenex
  • Xyzal (levocetirizine dihydrochloride)
  • Zagam (sparfloxacin) tablets
  • Zemaira (alpha1-proteinase inhibitor)
  • Zosyn (sterile piperacillin sodium/tazobactam sodium)
  • Zyflo (Zileuton)
  • Zyrtec (cetirizine HCl)

  • Back to top





    FDA Approved Listings:
    The rules of principle for evaluating MediLexicon's FDA Approval Listings adhere to the FDA definitions of a new drug approval or a new molecular entity, and the Tufts Center for the Study of Drug Development.

    MediLexicon's FDA Approved Drugs Listings include:
    New Molecular Entities (NME): these NME's are described as a medication containing an active substance that have never previously approved in the US for marketing in any manner, shape or form (as defined by the FDA). In addition to this, there is also the inclusion of some FDA's Center for Drug Evaluation and Research (CDER) approved recombinant proteins and biologics.

    MediLexicon's FDA Approved Drugs Listings do NOT include:
    Over-the-counter products, diagnostic agents, generics, most vaccines, medical devices, biologic compounds (not approved by CDER), as well as new indications and new administrations of previously-approved compounds and new dosages.


    Please note that the extra search boxes at the top of the website link to external drug website databases. In no event shall MediLexicon International Ltd be responsible for the content, accuracy or opinions expressed in these web sites.

    The Pulmonary/Respiratory Diseases FDA drug information used in this section is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.






    free web search box


    pda medical dictionary
    pda software - $15

    PDA Medical Dictionary

    only $15

    Take MediLexicon's abbreviations search with you where-ever you go with our PDA software. As an extra, this software is available with an extra medical dictionary...

    >> Click here for more on the PDA Medical Dictionary <<




    add to google

    Add our searches to your Google homepage.

    Add to Google

    The 60 seconds challenge: Add these searches to your Google homepage within 60 seconds - simply click here and follow these instructions


    Receive the latest medical news on your Google homepage.

    Add to Google

    The 60 seconds challenge: Receive the latest medical news on your Google homepage within 60 seconds - simply click here and follow these instructions





    Privacy Policy   |    Disclaimer      

    MediLexicon International Ltd, UK Office: +44 (0) 1625 415 347
    MediLexicon International Ltd © 2009 All rights reserved.